Tue, 16th Mar 2021 07:49
PARIS, March 16 (Reuters) - French vaccination chief Alain
Fischer said on Tuesday he expects the suspension of
AstraZeneca's COVID-19 vaccine in its inoculation
campaign to be temporary.
Fischer told France Inter radio that the number of cases of
people showing adverse side-effects from the vaccine remained
small.
He also said that the AstraZeneca vaccine was not a
second-tier vaccine.
(Reporting by Sudip Kar-Gupta and Matthieu Protard, editing by
Louise Heavens)
(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.
PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly ...
(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of Engla...
FTSE 100 up 0.5%, FTSE 250 adds 0.4% *
(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the...
Astrazeneca (AZN)